| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
10% Owner
2 companies
Column Group III Gp, LP is a 10% Owner at SRZN, with reported holdings spanning 2 companies. Recent filings cover 31 purchases and 12 sales. Those positions are worth an estimated $44.2M at current prices.
Our model assigns Column Group III Gp, LP a strong insider score of 74/100, based on 25 past trades. Over a 12-month horizon, 70.0% of those trades were profitable, with an average 12-month return of +34.8%.
Column Group III Gp, LP's largest disclosed position is in SRZN as 10% Owner, worth about $44.2M. Net of sales, the recent Form 4 record there shows accumulation of 1,645,237 shares.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Apr 4, 2024 | SRZN Surrozen, Inc./de | 10% Owner | Buy | 193,548 | $15.50 | $2,999,994.00 | +138.9% | -3.0% | -3.0% | |
| Feb 12, 2024 | TNYA Tenaya Therapeutics, Inc. | 10% Owner | Buy | 2,222,222 | $4.50 | $9,999,999.00 | +19.5% | -24.4% | -83.3% | |
| Mar 10, 2023 | TNYA Tenaya Therapeutics, Inc. | 10% Owner | Buy | 6,779 | $2.60 | $17,595.57 | - | +183.5% | +145.2% | |
| Feb 8, 2023 | TNYA Tenaya Therapeutics, Inc. | 10% Owner | Buy | 1,500,000 | $2.60 | $3,900,000.00 | +15.2% | +136.6% | +85.9% | |
| Jan 19, 2023 | TNYA Tenaya Therapeutics, Inc. | 10% Owner | Buy | 69,739 | $2.50 | $174,201.05 | +0.7% | +40.6% | +50.2% | |
| Jan 18, 2023 | TNYA Tenaya Therapeutics, Inc. | 10% Owner | Buy | 185,151 | $2.51 | $464,827.06 | +1.9% | +21.4% | +26.6% | |
| Nov 21, 2022 | TNYA Tenaya Therapeutics, Inc. | 10% Owner | Buy | 9,615,384 | $2.60 | $24,999,998.40 | New | +36.9% | -22.3% |